• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Impact of the revised International Prognostic Scoring System on the outcome of patients with acute myeloid leukemia with or without antecedent myelodysplastic syndrome.

作者信息

Stölzel F, Kramer M, Mohr B, Wermke M, Bornhäuser M, Ehninger G, Schaich M, Platzbecker U

机构信息

Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany.

Klinik für Hämatologie, Onkologie und Palliativmedizin, Rems-Murr-Klinik, Waiblingen, Germany.

出版信息

Leukemia. 2014 Mar;28(3):723-5. doi: 10.1038/leu.2013.356. Epub 2013 Nov 25.

DOI:10.1038/leu.2013.356
PMID:24270741
Abstract
摘要

相似文献

1
Impact of the revised International Prognostic Scoring System on the outcome of patients with acute myeloid leukemia with or without antecedent myelodysplastic syndrome.修订后的国际预后评分系统对伴或不伴既往骨髓增生异常综合征的急性髓系白血病患者预后的影响
Leukemia. 2014 Mar;28(3):723-5. doi: 10.1038/leu.2013.356. Epub 2013 Nov 25.
2
Complex or monosomal karyotype and not blast percentage is associated with poor survival in acute myeloid leukemia and myelodysplastic syndrome patients with inv(3)(q21q26.2)/t(3;3)(q21;q26.2): a Bone Marrow Pathology Group study.复杂或单体核型而非原始细胞百分比与急性髓系白血病和伴有inv(3)(q21q26.2)/t(3;3)(q21;q26.2)的骨髓增生异常综合征患者的不良生存相关：一项骨髓病理学组研究。
Haematologica. 2014 May;99(5):821-9. doi: 10.3324/haematol.2013.096420. Epub 2014 Jan 24.
3
Impact of the revised International Prognostic Scoring System, cytogenetics and monosomal karyotype on outcome after allogeneic stem cell transplantation for myelodysplastic syndromes and secondary acute myeloid leukemia evolving from myelodysplastic syndromes: a retrospective multicenter study of the European Society of Blood and Marrow Transplantation.修订后的国际预后评分系统、细胞遗传学和单倍体核型对骨髓增生异常综合征及由骨髓增生异常综合征演变而来的继发性急性髓系白血病异基因干细胞移植后结局的影响：欧洲血液和骨髓移植学会的一项回顾性多中心研究
Haematologica. 2015 Mar;100(3):400-8. doi: 10.3324/haematol.2014.116715. Epub 2014 Dec 31.
4
Application of the international prognostic scoring system-revised in therapy-related myelodysplastic syndromes and oligoblastic acute myeloid leukemia.国际预后评分系统修订版在治疗相关骨髓增生异常综合征和少原始细胞急性髓系白血病中的应用
Leukemia. 2014 Jan;28(1):185-9. doi: 10.1038/leu.2013.191. Epub 2013 Jun 21.
5
Infection and hemorrhage in elderly acute myeloblastic leukemia and primary myelodysplasia.老年急性髓系白血病和原发性骨髓增生异常综合征中的感染与出血
Hematol Oncol. 1993;11 Suppl 1:15-8.
6
The prognostic impact of loss of chromosome 7 material detected by fluorescence in situ hybridization (FISH) in myeloid malignancies.荧光原位杂交（FISH）检测到的7号染色体物质缺失在髓系恶性肿瘤中的预后影响。
J Egypt Natl Canc Inst. 2018 Dec;30(4):133-138. doi: 10.1016/j.jnci.2018.11.001. Epub 2018 Nov 22.
7
The quality and quantity of leukemia-derived dendritic cells from patients with acute myeloid leukemia and myelodysplastic syndrome are a predictive factor for the lytic potential of dendritic cells-primed leukemia-specific T cells.从急性髓系白血病和骨髓增生异常综合征患者中获得的白血病衍生树突状细胞的质量和数量是树突状细胞致敏的白血病特异性 T 细胞溶细胞潜能的预测因素。
J Immunother. 2010 Jun;33(5):523-37. doi: 10.1097/CJI.0b013e3181d87ffd.
8
Is this man's cancer related to his occupation?这个人的癌症与他的职业有关吗？
J Occup Environ Med. 2013 Jan;55(1):112-4. doi: 10.1097/JOM.0b013e3181e5a4ce.
9
Does mutational burden add to other prognostic factors in MDS?基因突变负担是否能为 MDS 的其他预后因素提供补充？
Best Pract Res Clin Haematol. 2019 Dec;32(4):101098. doi: 10.1016/j.beha.2019.101098. Epub 2019 Oct 18.
10
Clonal hematopoiesis-defining mutations have no impact on the development of thrombosis in a cohort of patients with myeloid pathology.
Leuk Res. 2021 Sep;108:106613. doi: 10.1016/j.leukres.2021.106613. Epub 2021 May 8.

引用本文的文献

1
[Myelodysplastic syndrome, acute leukemia and stem cell transplantation].[骨髓增生异常综合征、急性白血病与干细胞移植]
Z Rheumatol. 2017 Oct;76(Suppl 2):26-32. doi: 10.1007/s00393-017-0369-2.
2
Comparison of the prognostic utility of the revised International Prognostic Scoring System and the French Prognostic Scoring System in azacitidine-treated patients with myelodysplastic syndromes.比较阿扎胞苷治疗骨髓增生异常综合征患者中修订后的国际预后评分系统和法国预后评分系统的预后预测价值。
Br J Haematol. 2014 Aug;166(3):352-9. doi: 10.1111/bjh.12884. Epub 2014 Apr 9.

本文引用的文献

1
High-dose cytarabine consolidation with or without additional amsacrine and mitoxantrone in acute myeloid leukemia: results of the prospective randomized AML2003 trial.大剂量阿糖胞苷巩固治疗联合或不联合安吖啶和米托蒽醌治疗急性髓系白血病：前瞻性随机 AML2003 试验的结果。
J Clin Oncol. 2013 Jun 10;31(17):2094-102. doi: 10.1200/JCO.2012.46.4743. Epub 2013 Apr 29.
2
The revised IPSS is a powerful tool to evaluate the outcome of MDS patients treated with azacitidine: the GFM experience.修订后的国际预后评分系统（IPSS）是评估接受阿扎胞苷治疗的骨髓增生异常综合征（MDS）患者预后的有力工具：法国骨髓增生异常综合征研究组（GFM）的经验。
Blood. 2012 Dec 13;120(25):5084-5. doi: 10.1182/blood-2012-09-453555.
3
Five-group cytogenetic risk classification, monosomal karyotype, and outcome after hematopoietic cell transplantation for MDS or acute leukemia evolving from MDS.
五组细胞遗传学风险分类、单体核型和 MDS 或由 MDS 发展而来的急性白血病造血细胞移植后的结果。
Blood. 2012 Aug 16;120(7):1398-408. doi: 10.1182/blood-2012-04-423046. Epub 2012 Jul 5.
4
Revised international prognostic scoring system for myelodysplastic syndromes.修订版国际预后积分系统用于骨髓增生异常综合征。
Blood. 2012 Sep 20;120(12):2454-65. doi: 10.1182/blood-2012-03-420489. Epub 2012 Jun 27.
5
New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge.新的原发性骨髓增生异常综合征（MDS）和 MDS 衍生的少突细胞急性髓系白血病的综合细胞遗传学评分系统，源自国际数据库合并。
J Clin Oncol. 2012 Mar 10;30(8):820-9. doi: 10.1200/JCO.2011.35.6394. Epub 2012 Feb 13.
6
Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial.采用新预后评分对继发性急性髓系白血病患者进行风险分层：前瞻性 AML96 试验的结果。
Leukemia. 2011 Mar;25(3):420-8. doi: 10.1038/leu.2010.279. Epub 2010 Dec 7.
7
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trial.一项针对老年急性髓系白血病患者的新型预后模型：909 例前瞻性 AML96 试验患者的结果。
Blood. 2010 Aug 12;116(6):971-8. doi: 10.1182/blood-2010-01-267302. Epub 2010 May 4.
8
Refinement of cytogenetic classification in acute myeloid leukemia: determination of prognostic significance of rare recurring chromosomal abnormalities among 5876 younger adult patients treated in the United Kingdom Medical Research Council trials.在英国医学研究理事会试验中治疗的 5876 例年轻成年患者中，对罕见重现染色体异常进行细胞遗传学分类的细化：确定其预后意义。
Blood. 2010 Jul 22;116(3):354-65. doi: 10.1182/blood-2009-11-254441. Epub 2010 Apr 12.
9
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.成人急性髓系白血病的诊断和治疗：代表欧洲白血病网的国际专家小组的建议。
Blood. 2010 Jan 21;115(3):453-74. doi: 10.1182/blood-2009-07-235358. Epub 2009 Oct 30.
10
Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia.急性髓系白血病治疗试验的诊断、反应标准标准化、治疗结果及报告标准国际工作组修订建议
J Clin Oncol. 2003 Dec 15;21(24):4642-9. doi: 10.1200/JCO.2003.04.036.